EMA Authorised: Zebinix (eslicarbazepine acetate) — BIAL - Portela & Ca, S.A.

View source ↗

Summary

The European Medicines Agency has authorised Zebinix (eslicarbazepine acetate) by BIAL - Portela & Ca, S.A. for epilepsy. The decision date is 31 March 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Zebinix (eslicarbazepine acetate)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: BIAL - Portela & Ca, S.A.. Decision date: 31/03/2025